🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Long-term tacrolimus ointment based regimen comprising of up to 6 weeks of ...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00480610
Treatments Being Tested
Patients who have participated in previous studies with Tacrolimus ointment...
Status
Completed
Location
Multiple Locations
Start Date
1998-06
Trial ID
NCT00560378
Treatments Being Tested
Purpose: To compare the efficacy of topical 0.03% tacrolimus with systemic ...
Status
Unknown
Location
Ophthalmic Research Center
Start Date
2019-11
Trial ID
NCT04147390
Treatments Being Tested
The aim of this trial is to assess the efficacy of 0417 Ointment in the Tre...
Status
Completed
Location
Fougera Pharmaceuticals Inc.
Start Date
2008-01
Trial ID
NCT01139450
Treatments Being Tested
tacrolimus has been widely used as an immunosuppressant. the objective of t...
Status
Completed
Location
Noha Dawoud
Start Date
2019-05-20
Trial ID
NCT05139667
Treatments Being Tested
This clinical trial aims to compare the efficacy and safety of central nevu...
Status
Not Yet Recruiting
Location
Xijing Hospital
Start Date
2026-01-20
Trial ID
NCT07307534
Treatments Being Tested
The investigators believe that the emerging epidemiological evidence connec...
Status
Completed
Location
Department of Dermatology and Allergy
Start Date
2019-08-22
Trial ID
NCT04114097
The study to compare the outcomes of mini punch grafting in patients with r...
Status
Unknown
Location
Alexandria faculty of medicine
Start Date
2021-01-25
Trial ID
NCT04765826
Treatments Being Tested
A long-term 0.03% tacrolimus ointment based regimen comprising of up to 6 w...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00480896
Treatments Being Tested
This is a parallel group, Phase 3, multinational, multicenter, randomized, ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham- Site Number : 8401267
Start Date
2024-02-29
Trial ID
NCT06241118
Treatments Being Tested